Financials
- Market Capitalization 723.71 M
- Employee 113
- Founded 2009
- CEO N/A
- Website www.aurabiosciences.com
- Headquarter Delaware, United States
- FIGI BBG00226DGM5
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-3.91
ratio cours/chiffre d'affaires
67.11
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2643 | CLYM Climb Bio, Inc. - Common Stock | 13.24 USD | +0.23% | +0.76% | +15.03% | +142.05% | 758.13 M USD | ||
| 2646 | SPRY ARS Pharmaceuticals, Inc. - Common Stock | 7.61 USD | -1.68% | +0.13% | -22.35% | -17.37% | 755.70 M USD | ||
| 2679 | CADL Candel Therapeutics, Inc. - Common Stock | 9.87 USD | +2.39% | +2.49% | +16.39% | +55.92% | 723.18 M USD | ||
| 2692 | BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | 8.82 USD | +3.52% | +1.73% | +13.51% | -7.06% | 706.54 M USD |